Home
>
National Drug Code (NDC)
>
Dipyridamole
Dipyridamole - 0527-1461-05 - (Dipyridamole)
Drug Information of Dipyridamole
| Product NDC: | 0527-1461 |
| Proprietary Name: | Dipyridamole |
| Non Proprietary Name: | Dipyridamole |
| Active Ingredient(s): | 25 mg/1 & nbsp; Dipyridamole |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Dipyridamole
| Product NDC: | 0527-1461 |
| Labeler Name: | Lannett Company, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040898 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20080423 |
Package Information of Dipyridamole
| Package NDC: | 0527-1461-05 |
| Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (0527-1461-05) |
NDC Information of Dipyridamole
| NDC Code | 0527-1461-05 |
| Proprietary Name | Dipyridamole |
| Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (0527-1461-05) |
| Product NDC | 0527-1461 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Dipyridamole |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20080423 |
| Marketing Category Name | ANDA |
| Labeler Name | Lannett Company, Inc. |
| Substance Name | DIPYRIDAMOLE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
